BIOSITE INC 4
4 · BIOSITE INC · Filed Jul 2, 2007
Insider Transaction Report
Form 4
BIOSITE INCBSTE
WOLLAEGER TIMOTHY J
Director
Transactions
- Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−1,253→ 0 totalExercise: $44.18Exp: 2014-06-18→ Common Stock (1,253 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−4,062→ 0 totalExercise: $45.02Exp: 2016-11-01→ Common Stock (4,062 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−2,500→ 0 totalExercise: $53.38Exp: 2015-06-17→ Common Stock (2,500 underlying)
Footnotes (3)
- [F1]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 2,244 shares of Inverness common stock for $24.66 per share.
- [F2]This option, which provided for vesting in sixteen equal quarterly installments over a four-year period commencing on the date of grant was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 7,277 shares of Inverness common stock for $25.13 per share.
- [F3]This option, which provided for vesting in sixteen equal quarterly installments over a four-year period commencing on the date of grant was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 4,478 shares of Inverness common stock for $29.80 per share.